Health & Medicine
The Promise and Perils of GLP-1 Agonists: Revolutionizing Obesity and Diabetes Treatment
GLP-1 agonists like semaglutide and tirzepatide are transforming the management of obesity and type 2 diabetes. This article examines their mechanisms, benefits, risks, and the profound implications for public health.